OGI Organigram Global Inc.
Healthcare$1.11-0.89%ClosedMarket Cap: $156.3M
As of 2026-05-26
Valuation
P/E (TTM)
10.29
PEG
0.08
P/B
0.57
P/S
0.80
EV/EBITDA
-4.22
DCF Value
$-13.73
FCF Yield
-9.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-3.1%
Operating Margin
-38.6%
Net Margin
-9.2%
ROE
-6.8%
ROA
-4.8%
ROIC
-15.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $59.8M | -10.8% | $-9.8M | $-923.4K | $— | — |
| Q1 null | $63.5M | 36.7% | $-3.4M | $20.0M | $— | — |
| Q4 null | $80.1M | 39.8% | $1.2M | $-38.0M | $— | — |
| FY null | $186.1M | 3.7% | $-63.4M | $-17.8M | $— | — |
| Q3 null | $70.8M | 36.9% | $-2.1M | $-6.3M | $— | — |
| Q2 null | $65.6M | 28.1% | $-7.6M | $42.5M | $— | — |
| Q1 null | $42.7M | 32.3% | $-6.8M | $-23.0M | $— | — |
| Q4 null | $44.7M | 38.5% | $283.0K | $-5.4M | $— | — |
| FY null | $159.8M | 29.7% | $-35.7M | $-45.4M | $— | — |
| Q3 null | $41.1M | 34.1% | $-5.0M | $2.8M | $— | — |
| Q2 null | $37.6M | -2.4% | $-15.1M | $-27.1M | $— | — |
| Q1 2024 | $36.5M | 18.4% | $-15.9M | $-15.8M | $-0.19 | — |